Common Contracts

13 similar Underwriting Agreement contracts by Oculus Innovative Sciences, Inc., Celsius Holdings, Inc., Hq Sustainable Maritime Industries, Inc., others

NEW YORK MORTGAGE TRUST, INC. 2,750,000 Shares of Common Stock* UNDERWRITING AGREEMENT
Underwriting Agreement • May 31st, 2012 • New York Mortgage Trust Inc • Real estate investment trusts • New York

New York Mortgage Trust, Inc., a Maryland corporation (the “Company”), proposes to issue and sell, subject to the conditions hereinafter stated, to the several Underwriters named in Schedule I attached hereto (the “Underwriters”) an aggregate of 2,750,000 shares (the “Firm Securities”) of its common stock, $0.01 par value per share (“Common Stock”), pursuant to and in accordance with the terms and conditions of this underwriting agreement (this “Agreement”) in connection with the public offering (the “Offering”) and sale of such Firm Securities.

AutoNDA by SimpleDocs
NEW YORK MORTGAGE TRUST, INC. 1,500,000 Shares of Common Stock* UNDERWRITING AGREEMENT
Underwriting Agreement • June 30th, 2011 • New York Mortgage Trust Inc • Real estate investment trusts • New York

New York Mortgage Trust, Inc., a Maryland corporation (the “Company”), proposes to issue and sell, subject to the conditions hereinafter stated, to the several Underwriters named in Schedule I attached hereto (the “Underwriters”) an aggregate of 1,500,000 shares (the “Firm Securities”) of its common stock, $0.01 par value per share (“Common Stock”), pursuant to and in accordance with the terms and conditions of this underwriting agreement (this “Agreement”) in connection with the public offering (the “Offering”) and sale of such Firm Securities.

690,000 Units REPROS THERAPEUTICS INC. Each Unit consisting of 4 Shares of Common Stock and 3 Series A Warrants and 2.45 Series B Warrants UNDERWRITING AGREEMENT
Underwriting Agreement • February 9th, 2011 • Repros Therapeutics Inc. • Biological products, (no disgnostic substances) • New York

Based on the foregoing, and subject to the assumptions, qualifications and limitations set forth herein, as of the date hereof we are of the opinion that:

] Units REPROS THERAPEUTICS INC. Each Unit consisting of [ ] Shares of Common Stock and [ ] Series A Warrants and [ ] Series B Warrants UNDERWRITING AGREEMENT
Underwriting Agreement • February 2nd, 2011 • Repros Therapeutics Inc. • Biological products, (no disgnostic substances) • New York

Based on the foregoing, and subject to the assumptions, qualifications and limitations set forth herein, as of the date hereof we are of the opinion that:

900,000 Units CELSIUS HOLDINGS, INC. Each Unit consisting of Four Shares of Common Stock and One Warrant, each to Purchase One Share of Common Stock UNDERWRITING AGREEMENT
Underwriting Agreement • February 8th, 2010 • Celsius Holdings, Inc. • Bottled & canned soft drinks & carbonated waters • New York

CELSIUS HOLDINGS, INC, a Nevada corporation (the “Company”), proposes to issue and sell to the several Underwriters (as defined below) an aggregate of (i) 3,600,000 shares (the “Shares”) of its common stock, $0.001 par value per share (the “Common Stock”) and (ii) warrants (the “Warrants”) to purchase up to an aggregate of 900,000 shares of Common Stock (the “Warrant Shares”) pursuant to and in accordance with the terms and conditions of this underwriting agreement (the “Agreement”). The Shares and Warrants shall be sold in units (each a “Unit”), each Unit consisting of four (4) Shares and one (1) Warrant, each to purchase one (1) Warrant Share at the exercise price per share specified in the Prospectus (as defined below). The Shares and the Warrants shall be issued separately and shall be transferable separately immediately upon issuance. The Warrants will be issued pursuant to the terms of a Warrant Agreement (the “Warrant Agreement”) to be entered into by and between the Company and

900,000 Units CELSIUS HOLDINGS, INC. Each Unit consisting of Four Shares of Common Stock and One Warrant, each to Purchase One Share of Common Stock UNDERWRITING AGREEMENT
Underwriting Agreement • January 22nd, 2010 • Celsius Holdings, Inc. • Bottled & canned soft drinks & carbonated waters • New York

CELSIUS HOLDINGS, INC, a Nevada corporation (the “Company”), proposes to issue and sell to the several Underwriters (as defined below) an aggregate of (i) 3,600,000 shares (the “Shares”) of its common stock, $0.001 par value per share (the “Common Stock”) and (ii) warrants (the “Warrants”) to purchase up to an aggregate of 900,000 shares of Common Stock (the “Warrant Shares”) pursuant to and in accordance with the terms and conditions of this underwriting agreement (the “Agreement”). The Shares and Warrants shall be sold in units (each a “Unit”), each Unit consisting of four (4) Shares and one (1) Warrant, each to purchase one (1) Warrant Share at the exercise price per share specified in the Prospectus (as defined below). The Shares and the Warrants shall be issued separately and shall be transferable separately immediately upon issuance. The Warrants will be issued pursuant to the terms of a Warrant Agreement (the “Warrant Agreement”) to be entered into by and between the Company and

3,500,000 Shares and 3,500,000 Warrants OPEXA THERAPEUTICS, INC. Common Stock and Common Stock Purchase Warrants UNDERWRITING AGREEMENT February 13, 2008
Underwriting Agreement • February 14th, 2008 • Opexa Therapeutics, Inc. • Pharmaceutical preparations • California
4,500,000 Shares and 4,500,000 Warrants OPEXA THERAPEUTICS, Inc. Common Stock and Common Stock Purchase Warrants UNDERWRITING AGREEMENT
Underwriting Agreement • December 20th, 2007 • Opexa Therapeutics, Inc. • Pharmaceutical preparations • California

Opexa Therapeutics, Inc., a Texas corporation (“Company”), proposes to issue and sell to the several Underwriters (as defined below) an aggregate of 4,500,000 shares of its common stock, $0.50 par value per share (the “Common Stock”) and an aggregate of 4,500,000 common stock purchase warrants, each warrant to purchase one share of common stock for an exercise period of five years commencing the date of issuance (the “Public Series E Warrants”).

4,500,000 Shares HQ SUSTAINABLE MARITIME INDUSTRIES, INC. Common Stock UNDERWRITING AGREEMENT
Underwriting Agreement • November 8th, 2007 • Hq Sustainable Maritime Industries, Inc. • Fishing, hunting and trapping • New York
4,200,000 Shares HQ SUSTAINABLE MARITIME INDUSTRIES, INC. Common Stock UNDERWRITING AGREEMENT
Underwriting Agreement • May 24th, 2007 • Hq Sustainable Maritime Industries, Inc. • Fishing, hunting and trapping • New York
4,025,000 Shares OCULUS INNOVATIVE SCIENCES, INC. Common Stock UNDERWRITING AGREEMENT
Underwriting Agreement • January 3rd, 2007 • Oculus Innovative Sciences, Inc. • Surgical & medical instruments & apparatus • California

Roth Capital Partners, LLC As Representative of the Several Underwriters named in Schedule I hereto 24 Corporate Plaza Newport Beach, CA 92660

3,538,461 Shares OCULUS INNOVATIVE SCIENCES, INC. Common Stock UNDERWRITING AGREEMENT
Underwriting Agreement • December 20th, 2006 • Oculus Innovative Sciences, Inc. • Surgical & medical instruments & apparatus • California

Roth Capital Partners, LLC As Representative of the Several Underwriters named in Schedule I hereto 24 Corporate Plaza Newport Beach, CA 92660

3,538,461 Shares OCULUS INNOVATIVE SCIENCES, INC. Common Stock UNDERWRITING AGREEMENT
Underwriting Agreement • December 18th, 2006 • Oculus Innovative Sciences, Inc. • Surgical & medical instruments & apparatus • California

Roth Capital Partners, LLC As Representative of the Several Underwriters named in Schedule I hereto 24 Corporate Plaza Newport Beach, CA 92660

Time is Money Join Law Insider Premium to draft better contracts faster.